Gene Query: TGDS

Dataset Description Geneva Score
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 29.83
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 18.26
SRSF2 mutations impair hematopoiesis and alter exon recognition 16.01
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 14.59
DART-seq: an antibody-free method for global m6A detection 13.83
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 11.15
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 11.07
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.58
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.39
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 8.1
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.97
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.74
ETV7 and interferon response 7.74
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 6.85
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.79
Lysine benzoylation is a novel histone mark 6.62
Lysine benzoylation is a novel histone mark [RNA-seq] 6.62
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 5.27
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 5.26
R430: A potent inbibitor of DNA and RNA viruses 5.18
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.1
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.04
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.04
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.82
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.82
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.76
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.68
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.54
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 4.46
Zone dependent distinctive gene expression profile of the normal human liver tissue 4.45
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.33
RNA-seq of tumor cells following angiopellosis extravasation 4.19
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.08
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 4.08
Gene expression signatures of innate lymphoid cells from human blood 4.04
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.96
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.94
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.87
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.87
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.64
Cell responses to dysregulated VZV-induced cell-cell fusion 3.59
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.57
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 3.52
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.4
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.4
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.38
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.33
Transcriptome analysis of SKI knock-out in HL60 cells 3.33
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 3.27
Gene expression analysis of dengue-infected cells 3.22
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.17
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.16
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 3.14
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.12
Gene expression changes due to PARP knockdown in human cells 3.09
Proteomics identifies a marker signature of MAPKi resistance in melanoma 3.02
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.99
HEK293 TFAM Knockout Expression Study 2.98
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.96
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.87
Genome-wide discovery of human splicing branchpoints 2.81
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.81
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.79
Human cell line and subcutaneous tumor 2.68
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.66
Biological effect of chronic mistranslation in mammalian cells 2.66
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.65
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.65
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.64
Patient-derived xenograft platform for metastatic melanoma 2.62
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.6
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.58
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.55
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.55
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.55
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.55
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.53
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.47
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 2.47
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.46
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.41
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 2.36
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 2.34
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.31
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.3
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.3
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.3
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 2.28
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.26
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 2.26
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.19
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.19
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 2.17
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.13
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.13
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.09
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.07
FBXW7 modulates stress response by post-translational modification of HSF1 2.07
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.07
The DNA methylation landscape of human melanoma 2.04
The DNA methylation landscape of human melanoma [RNA-Seq] 2.04
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.02
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.02
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 2.01
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 2.01
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 2.01
RNA-seq data from human lymphoma cell lines 1.99
ChIP-seq and RNA-seq from human lymphoma cell lines 1.99
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 1.99
Differentially expressed genes post knock down of lincDUSP26 1.98
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 1.98
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.97
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.97
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.96
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.95
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.94
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.93
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 1.93
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 1.93
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 1.9
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 1.89
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 1.88
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.88
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.87
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.86
SF3B1 Degron knockdown RNA-seq 1.84
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 1.84
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 1.83
The regulartory role of ZCCHC24 in splicing machinery 1.82
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.81
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.81
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.79
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 1.79
RNAseq of HEK293 cells after Chtop knockdown 1.78
Co-transcriptional loading of RNA export factors shapes the human transcriptome 1.78
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.76
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 1.75
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 1.75
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.74
NHLRC1 re-expression in cancer cells 1.72
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.71
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.71
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.7
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.7
MYC dependent mRNA translation shapes gene expression and cell biology 1.69
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.68
Trans-differentiation of human adult peripheral blood T cells into neurons 1.66
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.66
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 1.65
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 1.65
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.64
Differential gene expression of human melanoma cells [RNA-seq] 1.63
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.63
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 1.61
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.61
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.61
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 1.6
Comparing gene expression in iPSC derived RPE from control and AMD donors 1.6
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.59
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.58
Seletive inhibition of CDK9 in DLBCL cell lines 1.58
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.57
IDH3a KO RNA-seq 1.56
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 1.55
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 1.55
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.54
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 1.53
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 1.52
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 1.52
Transcriptional responses of melanoma cells to BRAF inhibition 1.51
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 1.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.5
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.49
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.49
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.49
SNHG5 siRNA knock down in HCT116 cells 1.49
Systematic discovery of endogenous human ribonucleoprotein complexes 1.49
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.48
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.47
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.47
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.46
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 1.44
Regulation of protein translation during mitosis 1.44
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.43
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.42
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.42
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.39
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.39
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.39
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 1.38
Mapping interactions for the TNIP2 hub protein 1.37
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.37
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 1.37
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.37
Expression by CD133+ cells isolated from the adult human exocrine pancreas 1.37
Human Treg IFNg/IL-10 subpopulations 1.36
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.36
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.36
Integrating single-cell transcriptomic data across different conditions, technologies, and species 1.35
Single-cell analysis of adult human ovary using 10X genomics 1.35
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.34
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.34
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.34
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 1.33
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 1.33
Tracking distinct RNA populations using efficient and reversible covalent chemistry 1.33
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 1.33
Regulation of hypoxia-inducible factor activity by ZMYND8 1.32
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.31
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.31
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.3
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.3
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.3
LncRNA-GAS5 negative regulation of YAP-target genes expression 1.3
Developmental stage specific chromosome architecture in human erythroid cells 1.29
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 1.29
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.29
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 1.29
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.29
Transcriptional landscape changes during human embryonic stem cell derivation 1.29
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.28
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.27
Identifying the molecular mode of action of itraconazole in colorectal cancer 1.27
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 1.27
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.27
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.26
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.26
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 1.26
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.25
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 1.25
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.25
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.25
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.25
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.24
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.24
Nucleoporin-mediated regulation of cell identity genes 1.22
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 1.22
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.22
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.22
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.21
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.2
Identification of a LIF-responsive replication-competent human β cell 1.2
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.2
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.19
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.19
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 1.19
Identification of global XBP1s target gene expression in human prostate cancer cells 1.19
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.18
Gene expression in PANC1 cells treated with Rakicidin 1.18
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 1.18
mRNA expression profile of Lymphocytes 1.17
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 1.17
Illumina Total RNA-seq in HeLa 1.17
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.17
Controlling for gene expression changes in transcription factor protein networks. 1.16
IRF2 is a master regulator of human keratinocyte stem cell fate 1.16
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 1.16
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 1.15
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 1.15
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 1.15
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.15
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.14
Global Mapping of Human RNA-RNA Interactions 1.14
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.13
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.12
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.12
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.09
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 1.08
Determination of tRNA aminoacylation levels by high throughput sequencing 1.07
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.05
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.05
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 1.04
Gene expression analysis of human liver progenitor-like cells in culture 1.03
Functional significance of the HIV-1 Tat signature amino acid residues 1.03
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 1.01
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.01
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.01
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.0
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.99
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.97
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.97
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.96
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.96
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.95
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.95
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.94
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.94
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.94
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 0.94
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.93
A map of gene expression in neutrophil-like cell lines 0.93
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 0.93
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.93
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.92
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.92
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.92
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 0.91
Global transcriptome analysis of WT versus HEB-/- hESCs 0.88
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.88
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.87
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 0.86
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.86
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.85
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.83
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.83
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.83
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.83
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.82
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.82
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.81
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 0.81
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 0.81
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.79
PRDM1 inhibits proliferation of human colon cancer organoids 0.78
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.78
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.78
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.78
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.77
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.77
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.77
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.76
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.75
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.75
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 0.74
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.74
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.74
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.74
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.73
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 0.72
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.72
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.72
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.71
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.7
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.7
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.7
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.7
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.69
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.68
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.67
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.67
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 0.65
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 0.65
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.65
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.65
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.64
Accurate annotation of human protein-coding small open reading frames 0.64
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.63
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.62
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 0.61
Chromatin-informed inference of transcriptional programs in gynecologic cancers 0.61
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.6
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.6
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 0.59
The Genetic Landscape of Diamond-Blackfan Anemia 0.59
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 0.59
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.58
Modulation of nonsense-mediated decay by rapamycin 0.58
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 0.58
Effect of drugs on transcriptomic profiles 0.58
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.57
RNA-Seq from human ILC transitional populations 0.57
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.56
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.56
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.56
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.55
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 0.55
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.54
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.53
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.52
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.52
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.52
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.51
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.51
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.51
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.5
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 0.5
The contribution of Alu exons to the human proteome 0.5
Tracking of dCas9-methyltransferase footprints 0.5
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 0.5
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.48
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.48
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.48
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.48
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.48
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.48
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.47
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.47
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.47
The cytokine environment influence on human skin-derived T cells 0.47
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.46
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.46
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.46
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.44
Transcriptome of EBV-infected gastric cancer cell lines 0.44
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.43
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.43
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.43
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.43
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.43
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.43
Human Treg IL-12 stimulation 0.42
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.41
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.4
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.39
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.38
Analyses of T-ALL (COG study) 0.38
RNA sequencing of T-ALL (COG study) 0.38
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.38
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.38
Human Treg NaCl stimulation 0.38
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.37
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.37
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.37
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.36
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.35
O-glcnAc reprograms cellular energetics 0.35
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.35
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.34
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.34
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.33
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.33
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.33
Oncogenic roles of ARID5B in T-ALL 0.33
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.32
RNA-seq data 0.31
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.3
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.3
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.3
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.29
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.29
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.29
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.29
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.29
Global transcriptome analysis of HAP1 cells 0.29
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.28
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.28
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.28
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.27
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.26
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.26
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.26
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.25
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.25
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.24
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.24
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.23
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 0.23
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.22
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.22
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.22
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.21
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.21
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.21
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.21
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.2
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.2
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.2
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.2
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.19
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.18
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 0.18
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.16
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.15
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.14
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 0.13
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.13
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.13
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.13
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.13
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.12
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.11
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.11
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.1
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.1
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.09
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.09
RNA seq analysis of human Fetal and adult derived Enterospheres 0.08
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.07
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.07
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.07
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.06
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.06
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.05
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.05
Genome-wide analysis of the Integrator complex 0.04
Genome-wide analysis of the Integrator complex (HTS) 0.04
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.04
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.03
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.03
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.03
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.03
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.03
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.03
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.01
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.01
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation